HBK Investments’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-100,100
Closed -$9.71M – 798
2019
Q3
$9.71M Buy
+100,100
New +$10M 0.12% 122
2018
Q3
– Sell
-200,100
Closed -$20.5M – 1429
2018
Q2
$20.5M Buy
+200,100
New +$15.4M 0.13% 82

HBK Investments's ONCE Position: Q4 2019 in Review

HBK Investments sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 100,100 shares — an estimated $9.71M sold.

HBK Investments first reported a position in ONCE in Q2 2018 and held it in 2 quarters. The position peaked at $20.5M in Q2 2018. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • HBK Investments reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • HBK Investments sold 100,100 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $9.71M.
  • HBK Investments first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • HBK Investments's Spark Therapeutics, Inc. Common Stock position peaked at $20.5M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on HBK Investments's 13F filing for Q4 2019, filed 14 Feb 2020.